alt

Antiemetic Protocols and Palliative Care Workshop

Shared on November 18, 2026

Oncology Supportive Care and Palliative Chemotherapy

Overview

A teaching session on chemotherapy supportive care, antiemetic counselling, selected colorectal cancer treatments, and the goals of palliative chemotherapy. It concludes with instructions for a case-based workshop using the NHS England Palliative Care Guideline.

Key Concepts

  • Follow the specified antiemetic protocol: Do not change a regimen’s emetic-risk category unless the protocol or prescriber directs it.
  • Counselling is essential: Explain how and when to take supportive medicines, their side effects, and when to seek help.
  • Palliative chemotherapy prioritizes quality of life: Treatment benefits should outweigh its burdens; dose reduction or stopping treatment may be appropriate when toxicity becomes problematic.
  • KRAS status guides cetuximab use: Cetuximab is used for patients with KRAS wild type, not those with a KRAS mutation.

Detailed Notes

Antiemetic regimen and counselling

  • The example protocol classifies emetic risk as moderate on day one and low on day two. This is specific to that protocol; for other regimens, use the assigned risk category consistently unless instructed otherwise.
  • The pre-chemotherapy dexamethasone dose covers day one in the usual schedule. A higher-risk patient may have additional dexamethasone prescribed by the consultant.
  • Counselling should clarify that ondansetron is taken before chemotherapy and continued at home as prescribed.
  • A dopamine antagonist may be prescribed, for example metoclopramide or domperidone. Explain the prescribed dose and frequency, and that it may continue as needed for the following days.
  • Ondansetron can cause constipation. In a FOLFOX regimen, however, 5-FU can cause diarrhoea, so both effects may be relevant.
  • If dexamethasone is taken at home, take doses with breakfast and lunch; avoid taking the second dose after 2 p.m. because it can disrupt sleep.

Managing treatment-related symptoms

  • Loperamide: Use as directed for acute diarrhoea. The example advice is an initial two tablets or capsules, then one after each loose stool, up to a maximum of eight in 24 hours. Oncology patients should also be told when to seek medical advice and to maintain fluid intake.
  • Difflam (benzydamine) mouthwash: Swish 10 mL four times daily and spit it out; it is not meant to be swallowed. It may temporarily affect the taste of food. Maintain good oral hygiene and use a soft toothbrush to reduce gum injury.

Colorectal cancer treatments

  • KRAS is an oncogene. A KRAS mutation can confer resistance to cetuximab, an epidermal growth factor receptor (EGFR) inhibitor. Cetuximab is therefore used for patients with KRAS wild-type disease.
  • FOLFOX combines folinic acid, 5-FU, and oxaliplatin.
  • FOLFIRI combines folinic acid and 5-FU with irinotecan instead of oxaliplatin.
  • Atropine may be given before irinotecan, particularly in the first FOLFIRI cycle, to reduce cholinergic side effects such as diarrhoea.

Palliative chemotherapy

  • Palliative treatment is not intended to cure. Its primary aim is to relieve symptoms and improve quality of life; it may sometimes extend survival, but this is not guaranteed.
  • Treatment should continue only when its expected clinical benefit outweighs its risks and side effects.
  • Unlike curative treatment, palliative treatment does not require maintaining full dose intensity. Dose reductions may be made more readily, and treatment may be stopped if it becomes too burdensome.

Palliative care workshop

  • The workshop uses the NHS England Palliative Care Guideline as its reference for the case studies.
  • Answers may differ from those in other resources, such as the BNF; the guideline is being used specifically for the workshop cases.
  • The guideline includes symptom-management sections and drug-specific subsections. Participants are expected to consult it rather than already know its contents.
  • Answers to the 5-FU mechanism-of-action question will be posted on Moodle after the final palliative care workshop.
Browse all public notes